Serum kinetics of the anti-cancer agent 4-hydroxyandrostenedione in the rat
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
1984 • 235 citations
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.
1987 • 234 citations
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
1986 • 211 citations
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
1989 • 136 citations
4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer
1987 • 79 citations
Biochemistry of steroid hormones
1977 • 66 citations
Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer
1987 • 53 citations
Aromatase inhibitors and their use in controlling oestrogen-dependent processes
1979 • 52 citations
Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat
1986 • 45 citations
Antibodies to 4-hydroxyandrostenedione ? a new anti-breast cancer agent suitable for use in a radioimmunoassay
1987 • 6 citations
Radioimmunoassay of the anti-cancer agent 4-hydroxyandrostenedione in body fluids
1990 • 6 citations
Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproate
1988 • 3 citations